España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Penny Stock
Trump's Newly Listed DJT 'Doesn't Deserve This Valuation,' Says Expert: 'In Any Other World...This Would Be A Penny Stock'
RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
Insiders Buying ProtoKinetix And 2 Other Stocks Under $2
RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
Insiders Buying ProtoKinetix And 2 Other Stocks Under $2
Context Therapeutics And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
3 Stocks Insiders Are Buying: NextEra Energy And More
Context Therapeutics And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
3 Stocks Insiders Are Buying: NextEra Energy And More
Applied Digital And This Penny Stock Insiders Are Aggressively Buying
CalAmp And 2 Other Stocks Under $5 Insiders Are Aggressively Buying
Read More...
Penny Stock Recent News
Why Genius Brands Stock Is Trading Higher Today
A media penny stock is trading higher with news out that it could be launching a product that ties in with one of the hottest IPOs of the week.
The Penny Stock Behind Blockbuster Surges 1,400%: Rise From The Dead Or Mistaken Identity?
Movie rental chain Blockbuster went bankrupt in 2010 and has been an afterthought thanks to the rise of Netflix Inc (NASDAQ: NFLX).
Zomedica's Stock Spikes 90% And 'Tiger King' Star Carole Baskin Could Be The Reason
A penny stock popped Monday and “Tiger King” star Carole Baskin could be the reason.
5 Former SPACs That Are Now Penny Stocks Under $5
One of the hottest investment trends of 2020 has been the rise of specialty purpose acquisition companies, commonly known as SPACs.
ChinaCache CEO Resigns Amid Bribery Investigation
Vistagen Shares Fall Under $1 After Depression Drug Flunks Midstage Trial
KeyBanc Sounds Cautious Note On AK Steel's Q1